Dhaka, Oct. 17 -- For decades, the robust immunisation programs of Bangladesh, a cornerstone of its public health success, were entirely dependent on imported vaccines. During the pandemic, this dependency often placed the nation in a vulnerable position, leading to supply shortages and subsequently delaying critical vaccination programs. While the pharmaceutical sector has expanded remarkably over the past two decades, vaccine manufacturing was long considered beyond the technical and infrastructural reach of the nation itself.

That perception has now changed. With the establishment of a world-class vaccine manufacturing facility by a local company, Bangladesh has entered a new era-one where it not only produces vaccines for its own pop...